These data could be supported by recent evidence that VEGF production in HSCs was associated with overexpression of cyclooxygenase-2 via ERK activation [37] and that activation of PI3K/AKT/mTOR signalling increased VEGF secretion in tumour cells [7]. This evidence concerns the gene PTGS2 and neoplasm.